Open Insulin, ‘DIY bio’ and the future of pharma
The status quo of the U.S. pharmaceutical market may soon be turned on its head, according to CSU scientists.
The status quo of the U.S. pharmaceutical market may soon be turned on its head, according to CSU scientists.